Previous studies showed that bortezomib induced G2/M cell-cycle arrest in neuroblastoma, CD30-positive anaplastic large cell lymphoma, and mantle cell lymphoma [16,48,49]. Here, TNFRSF8 is linked to mantle cell lymphoma.